PepGen Inc
For the period ended Dec 31, 2023. Filed Mar 6, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 6, 2024.
| PEPGEN INC. | |
| By: | /s/ James McArthur |
| Name: | James McArthur |
| Title: | Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated as of March 6, 2024.
| Name | Title |
|---|---|
| /s/ James McArthur | Chief Executive Officer(Principal Executive Officer) |
| James McArthur, Ph. D. | |
| /s/ Noel Donnelly | Chief Financial Officer(Principal Financial Officer and Principal Accounting Officer) |
| Noel Donnelly, M.B.A. | |
| /s/ Laurie B. Keating | Chairperson of the Board of Directors |
| Laurie B. Keating, J.D. | |
| /s/ Christopher Ashton | Director |
| Christopher Ashton, Ph.D. | |
| /s/ Habib Joseph Dable | Director |
| Habib Joseph Dable | |
| /s/ Heidi Henson | Director |
| Heidi Henson | |
| /s/ Howard Mayer | Director |
| Howard Mayer, M.D. | |
| /s/ Joshua Resnick. | Director |
| Joshua Resnick, M.D., M.B.A | |
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 185) | F-2 |
|---|---|
| Consolidated Financial Statements as of and for the Year Ended December 31, 2023 and 2022: | |
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Operations | F-4 |
| Consolidated Statements of Comprehensive Loss | F-5 |
| Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.